MedTrace Logo

Use of a Remote-Monitoring System to Diagnose and Treat Obstructive Sleep Apnea

NCT00561860 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2014-03-17

No results posted yet for this study

Summary

Although continuous positive airway pressure (CPAP) is an effective therapy for obstructive sleep apnea-hypopnea (OSAH), one of the major impediments to its use is poor compliance. Adherence with CPAP ranges from 50% to 75%, and subjective reports underestimate actual use. The primary objectives are to determine whether a remote monitoring system improves 3 month compliance (average hours of use/night), and reduces the costs of caring for patients with OSAH who are prescribed CPAP.

Conditions

  • Obstructive Sleep Apnea-hypopnea

Interventions

DEVICE

Telemedicine Arm

Telemedicine involves the provision or support of direct clinical care via the application of electronic and communicating technology, including the remote monitoring of health status. By providing patient data early in the course of CPAP prescription, we believe that this technology would be immensely useful in improving compliance and acceptance of the device in patients with sleep apnea.

Sponsors & Collaborators

  • Philips Respironics

    collaborator INDUSTRY

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Najib Ayas, MD, MPH · University of British Columbia

  • Lisa Cortes, RT · University of British Columbia

  • John Fleetham, MD · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2010-09-30
Completion
2010-09-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00561860 on ClinicalTrials.gov